Recent Development in Platinum Complexes with Anticancer Activities and the Underlying Mechanisms

CHEN Tian-feng,LI Lin-lin,YU Lian-ling,YANG Fang,ZHENG Wen-jie
DOI: https://doi.org/10.3969/j.issn.1000-9965.2012.01.019
2012-01-01
Abstract:Cisplatin has been approved and widely used as anticancer drugs in clinical application since 1970s.Although cisplatin exhibited excellent and broad-spectrum anticancer activities,its low solubility,high toxicity,drug resistance,and other adverse side effects have limited its clinical applications.To obtain anticancer complexes 4with high efficacy and low toxicity,scientists have synthesized thousands of platinum complexes and have acquired gradual improvement.This paper reviews the recent developments in platinum complexes with anticancer activities and the underlying mechanisms.The complexes were classified as ①sterically hindered platinum(II) complexes;②multinuclear platinum(II) complexes;③ platinum(II) complexes with P or S as coordination atom;④other platinum(II) complexes with small ligands;⑤platinum(IV) complexes and so on.
What problem does this paper attempt to address?